|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Drospirenone/ethinyl estra- diol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors 显示文摘 | Tfayli H Ulnach JW Lee S | 2011 | Journal of Clinical Endocrinology & Metabolism2011，96，5： | 1 |
| 2 | Expression,prognostic and predictive impact of VEGF and bFGF in nonsmall cell lung cancer显示文摘 | Farhat F S Tfayli A Fakhruddin N | | 0，，02： | 1 |
| 3 | Expression,prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer显示文摘 | Farhat FS Tfayli A Fakhruddin N | | 0，，02： | 1 |
| 4 | Granu locytic sarcoma manifesting as multiple skeletal lesions 显示文摘 | HAMADANI M TFAYLI A SETHI S | 2005 | Am J Med Sci2005，330，： | 1 |
| 5 | Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell anti- body-negative versus positive patients 显示文摘 | Tfayli H Bacha F Gungor N | 2009 | Diabetes2009，58，： | 1 |
| 6 | Activity of combination chemotherapy, docetaxel and epirubicin as neoadjuvant therapy for women with breast cancer 显示文摘 | Tfayli A Holter J Bova A | 2006 | Anticancer Res2006，26，6： | 1 |
| 7 | Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors显示文摘 | Tfayli A Hentschel P Madajewicz S | 1999 | J Neurooncol1999，42，1： | 1 |
| 8 | Granulocytic manifesting as multiple skeletal lesions显示文摘 | Hamadani M Tfayli A Sethi S | 2005 | Am J Med Sci2005，330，3： | 1 |
| 9 | Expression, prognostic and predictive impact of VEGF and Bfgf in non-small cell lung cancer显示文摘 | FARHAT FS TFAYLI A FAKHRUDDIN N | 2012 | Crit Rev Oncol Hematol2012，84，2： | 1 |
| 10 | Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer 显示文摘 | Farhat F S Tfayli A Fakhruddin N | 2012 | Critical reviews in oncology/hematology2012，84，2： | 1 |
| 11 | Heat shock proteins in cancer:targeting the' chaperones'显示文摘 | Nahleh Z Tfayli A Najm A | 2012 | Future Med Chem2012，4，7： | 1 |
| 12 | Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer 显示文摘 | Farhat FS Tfayli A Fakhruddin N | 2012 | Crit Rev Oncol Hematol2012，84，2： | 1 |
| 13 | Neoadjuvant therapy with celeCoxib to women with early stage breast cancer 显示文摘 | Tfayli A Yang J Kojouril K | 2008 | Neoplasma2008，55，2： | 1 |
| 14 | Phenotypic type 2 diabetes inobese youth: insulin sensitivity and secretion in islet cell antibody-negative versus-positive patients显示文摘 | Tfayli H Bacha F Gungor N | 2009 | Diabetes2009，58，： | 1 |
| 15 | Treatment of metastatic breast cancer: state-of- the-art, subtypes and perspectives显示文摘 | EL SAGHIR N S TFAYLI A HATOUM H A | 2011 | Crit Rev Oncol Hematol2011，80，3： | 1 |
| 16 | Expression, prog- nostic and predictive impact of VEGF and bFGF in non- small cell lung cancer显示文摘 | Farhat FS Tfayli A Fakhruddin N | 2012 | Crit Rev Oncol Hematol2012，84，2： | 1 |
| 17 | Expression, prognostic and predictive impact ofVEGF and bFGF in non-small cell lung cancer显示文摘 | Farhat FS Tfayli A Fakhruddin N | 2012 | Crit Rev Oncol Hematol2012，84，2： | 1 |
| 18 | Activity of combination chemother-apy ,docetaxel and epirubicin as neoadjuvant therapy for women withbreast cancer显示文摘 | Tfayli A Holter J Bova A | 2006 | Anticancer Res2006，26，6： | 1 |
| 19 | Menstrual health and the metabolic syndrome in sdolescents显示文摘 | Tfayli H Arslanian S | 2008 | Ann N Y Acad Sci2008，1135，： | 1 |
| 20 | Expression, prognosticand predictive impact of VEGF and bFGF in non-small cell lung can-cer显示文摘 | Farhat FS Tfayli A Fakhruddin N | 2012 | Crit Rev Oncol Hematol2012，84，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员